Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
This study has been completed.
Sponsor:
Imperial College London
Collaborator:
Department of Health, United Kingdom
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00159250
First received: September 8, 2005
Last updated: February 22, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2009 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
No publications provided by Imperial College London
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):